The FDA will not enforce a decades-old policy requiring mifepristone be dispensed in person, citing the risk of COVID-19 exposure for to patients and providers.
from FDA pauses enforcement of in-person dispensing requirement for abortion pill
https://ift.tt/3wS34Tz
https://ift.tt/eA8V8J
No comments:
Post a Comment